Position in LEGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,473,153
-$287,648 QoQ
Shares Held
191,993
+73.2% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trexquant Investment LP holds $587,455,425 across 144 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
505,160 | $35,376,354 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,839 | $26,088,290 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
120,122 | $22,496,448 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
83,679 | $20,482,108 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
556,385 | $18,577,695 | |
| 6 | INSM |
INSMED Inc
|
156,553 | $16,691,680 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
275,712 | $15,164,160 | |
| 8 | EXEL |
Exelixis, Inc.
|
275,209 | $14,974,121 |
All Filings in LEGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,473,153 | 191,993 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $3,760,801 | 110,840 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $3,730,232 | 76,549 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,362,428 | 53,340 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $1,561,351 | 25,949 | Shares | Sole | 2024-02-09 | |
| 2022-09-30 | $1,942,284 | 47,605 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $304,020 | 8,366 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $287,490 | 6,168 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $727,052 | 14,380 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $418,627 | 10,198 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||